文献速递心脑血管急症重症综合管理与镇静镇痛

短潜伏期体感诱发电位用于重型动脉瘤性蛛网膜下腔出血手术或介入治疗前评估的前瞻性观察队列研究

[Use of somatosensory evoked potentials for preoperative assessment in patients with severe aneurysmal subarachnoid hemorrhage before surgical or interventional treatment: a prospective observational cohort study].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2018-01-01
一句话结论在重型aSAH术前评估中,SLSEP Judson III级预测3个月不良结局的敏感度90.5%、特异度84.6%,优于WFNS V级和改良Fisher IV级,作者认为SLSEP似乎更准确、可作为术前评估的有效辅助工具。

该前瞻性观察队列研究纳入2016年11月至2017年4月首都医科大学附属北京天坛医院ICU收治的WFNS IV或V级重型aSAH患者,发病12小时内行SLSEP监测并按Judson量表分级,同时以改良Fisher分级评估入院CT,3个月时以mRS评分(0-3分为结局良好,4-6分为结局不良)随访。最终34例纳入分析,结局不良组21例、结局良好组13例。单因素分析显示两组WFNS分级、改良Fisher分级和SLSEP Judson分级差异有统计学意义;WFNS V级和改良Fisher IV级的敏感度、特异度、阳性预测值、阴性预测值均低于85%,而SLSEP Judson III级分别为敏感度90.5%、特异度84.6%、阳性预测值90.5%。多因素Logistic分析仅Judson III级为不良结局的独立危险因素(OR=45.73,95%CI 4.25-499.31,P=0.002),WFNS V级(OR=1.14,95%CI 0.12-13.06,P=0.912)和改良Fisher IV级(OR=7.22,95%CI 0.51-113.20,P=0.160)仅与不良结局相关但无显著独立性。作者认为,与WFNS分级和改良Fisher分级相比,SLSEP在预测重型aSAH手术或介入治疗前长期结局方面似乎更准确,可能作为术前评估的有效辅助工具。

要点

  • 在WFNS IV或V级重型aSAH患者中,发病12小时内SLSEP Judson III级预测3个月不良结局的敏感度90.5%、特异度84.6%、阳性预测值90.5%。
  • 多因素Logistic分析显示,仅SLSEP Judson III级为不良结局的独立危险因素(OR=45.73,95%CI 4.25-499.31,P=0.002)。
  • WFNS V级(OR=1.14,95%CI 0.12-13.06,P=0.912)和改良Fisher IV级(OR=7.22,95%CI 0.51-113.20,P=0.160)仅与不良结局相关,无显著独立性。
  • WFNS V级和改良Fisher IV级的敏感度、特异度、阳性预测值、阴性预测值均低于85%,而SLSEP Judson III级上述指标均较好。
  • 作者认为,SLSEP似乎比WFNS分级和改良Fisher分级更准确预测重型aSAH术前长期结局,可能作为术前评估的有效辅助工具。

适用人群与场景

  • 2016年11月至2017年4月首都医科大学附属北京天坛医院ICU收治的WFNS IV或V级重型动脉瘤性蛛网膜下腔出血患者。
  • 最终纳入34例,其中结局不良组21例、结局良好组13例;7例因SLSEP监测结果受干扰被排除。

诊断标准与关键阈值

  • SLSEP监测于发病12小时内进行,结果按Judson量表分级,Judson III级为本文分析的预测指标。
  • 入院头颅CT按改良Fisher分级评估,改良Fisher IV级为本文分析的预测指标。
  • 发病后3个月按改良Rankin量表(mRS)评分,mRS 0-3分为结局良好,4-6分为结局不良。

研究设计与关键结果

  • 前瞻性观察队列研究,最终纳入34例WFNS IV或V级重型aSAH患者,结局不良组21例、结局良好组13例。
  • 两组性别、年龄、BMI、发病至治疗时间延迟及治疗方式选择差异无统计学意义;两组WFNS分级、改良Fisher分级和SLSEP Judson分级差异有统计学意义。
  • SLSEP Judson III级预测不良结局的敏感度90.5%、特异度84.6%、阳性预测值90.5%;WFNS V级和改良Fisher IV级的敏感度、特异度、阳性预测值、阴性预测值均低于85%。
  • 多因素Logistic分析仅Judson III级为不良结局独立危险因素(OR=45.73,95%CI 4.25-499.31,P=0.002);WFNS V级(OR=1.14,95%CI 0.12-13.06,P=0.912)和改良Fisher IV级(OR=7.22,95%CI 0.51-113.20,P=0.160)仅相关无显著独立性。

证据类型、等级与局限

  • 证据类型:前瞻性观察队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对WFNS IV或V级重型aSAH患者,发病12小时内行SLSEP监测并按Judson量表分级,可能有助于在手术或介入治疗前辅助预测3个月不良结局(作者认为SLSEP似乎更准确、可能作为术前评估的有效辅助工具)。
  • 与WFNS分级和改良Fisher分级相比,SLSEP Judson III级预测不良结局的敏感度、特异度、阳性预测值均较高,而WFNS V级和改良Fisher IV级上述指标均低于85%。
  • 多因素分析中仅SLSEP Judson III级为不良结局的独立危险因素,WFNS V级和改良Fisher IV级无显著独立性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the application value of short latency somatosensory evoked potentials (SLSEP) as a tool for preoperative assessment of surgical or interventional treatment in patients with severe aneurysmal subarachnoid hemorrhage (aSAH).

METHODS: A prospective observational cohort study was conducted. The patients with severe aSAH with a WFNS grade of IV or V admitted to intensive care unit (ICU) of Beijing Tiantan Hospital of Capital Medical University from November 2016 to April 2017 were enrolled. The patients received SLSEP monitoring within 12 hours after onset, and the monitoring results were classified according to the Judson scale. Meanwhile, the findings on cerebral CT scans at admission were evaluated by the modified Fisher classification. The follow-up was performed at 3 months after aSAH ictus based on the modified Rankin scale (mRS), and a mRS score 0-3 was defined as favorable outcome, 4-6 was defined as unfavorable outcome. For statistical evaluation, demographic, clinical, neuroimaging and SLSEP data were evaluated by univariate analysis to identify the risk factors associated with prognosis; afterwards, those factors were analyzed by multivariate Logistic regression; also the validity was assessed by calculating the respective sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV).

RESULTS: A total of 41 patients with aSAH were selected, of which 7 were excluded because of the interference of the SLSEP monitoring results, 34 patients with aSAH were enrolled finally. Among them, 21 were classified in the unfavorable outcome group, while the rest (n = 13) were allocated into the favorable outcome group. No significant difference was found in gender, age, body mass index (BMI), time delay from ictus to treatment or the options for therapeutic methods between the two groups. The findings of univariate analysis, however, showed statistically differences in WFNS grade, the modified Fisher scale and Judson scale of SLSEP between the two groups. Yet, the further validity evaluation for these predictors demonstrated that the sensitivity, specificity, PPV and NPV of WFNS grade of V and modified Fisher scale of IV were all less than 85%, whereas the results for SLSEP Judson scale of III were much better (sensitivity: 90.5% vs. 71.4% and 71.4%, specificity: 84.6% vs. 69.2% and 76.9%, PPV: 90.5% vs. 79.0% and 83.3%). In the following multivariate Logistic analysis, only Judson scale of III was identified to be the independent risk factor for poor outcome [odds ratio (OR) = 45.73, 95% confidence interval (95%CI) = 4.25-499.31, P = 0.002], while the WFNS grade of V (OR = 1.14, 95%CI = 0.12-13.06, P = 0.912) and the modified Fisher scale of IV (OR = 7.22, 95%CI = 0.51-113.20, P = 0.160) were merely associated with poor outcomes without significant independence.

CONCLUSIONS: In comparison with WFNS grade and the modified Fisher scale, SLSEP seems more accurate in the prediction of long-term outcome of severe aSAH prior to surgical or interventional treatment, and thus may be applied as an effective aid in preoperative assessment.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhao J, Luo X, Zhang Z, et al. [Use of somatosensory evoked potentials for preoperative assessment in patients with severe aneurysmal subarachnoid hemorrhage before surgical or interventional treatment: a prospective observational cohort study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 29519285. doi:10.3760/cma.j.issn.2095-4352.2018.03.012

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。